Trial intelligence / Profile preview

Ondansetron, paracetamol, and nefopam for prevention of shivering during cesarean section

PACTR202604906314523Phase 3Completed

Sponsor
Dr Anokwute Iheanyi Ihunanya
Start
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of ondansetron, acetaminophen and nefopam (4 arms), sponsored by Dr Anokwute Iheanyi Ihunanya. Primary endpoint: Incidence of shivering. Started Apr 2025; status: completed.

02

Drugs

ondansetronacetaminophennefopam

Beyond the preview

Go deeper on PACTR202604906314523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202604906314523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call